Kubota Pharmaceutical Holdings Co., Ltd. (TYO:4596)
74.00
+1.00 (1.37%)
Jul 16, 2026, 9:24 AM JST
TYO:4596 Revenue
Kubota Pharmaceutical Holdings had revenue of 4.69M JPY in the quarter ending March 31, 2026, a decrease of -35.21%. This brings the company's revenue in the last twelve months to 18.78M, down -36.10% year-over-year. In the year 2025, Kubota Pharmaceutical Holdings had annual revenue of 21.00M, down -22.22%.
Revenue (ttm)
18.78M
Revenue Growth
-36.10%
P/S Ratio
578.26
Revenue / Employee
2.35M
Employees
8
Market Cap
10.86B
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 21.00M | -6.00M | -22.22% |
| Dec 31, 2024 | 27.00M | -12.00M | -30.77% |
| Dec 31, 2023 | 39.00M | 31.00M | 387.50% |
| Dec 31, 2022 | 8.00M | - | - |
| Dec 31, 2021 | - | - | - |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| RaQualia Pharma | 3.82B |
| StemCell Institute | 2.81B |
| ReproCELL | 2.23B |
| Immuno-Biological Laboratories | 1.00B |
| OncoTherapy Science | 808.00M |
| Stella Pharma | 323.00M |
| SUSMED,Inc. | 274.00M |
| Nano Holdings | 174.00M |